Public Reporting

ACO Name and Location

Antelope Valley ACO, Inc.

44215 15th Street West #115

Lancaster, California 93534

 

ACO Primary Contact

Cessy Martinez, LVN

Operations Manager

Email: cmartinez@antelopevalleyaco.com

Phone: (661) 948-8000

Cell: (661) 349-6791

 

 

Organizational Information

ACO Participants

ACO Participant
in
 Joint Venture
(Enter Y or N)

Ravi S. Shankar,
MD, Inc.    

Y

Antelope Valley Cardiology Associates

Y

K. Sivakumar, MD, Inc.

Y

Ric Garrison

Y

Kim Horowitz

Y

Reen Medical Group, Inc.

Y

Satya Dandamudi

Y

Bryan Benefiel

Y

Terry Warsaw    

Y

Russell Greif    

Y

Richard Kling

Y

Sierra Gastroenterology

Y

Gonzalo Gonzalez Martinez, MD, Inc.    

Y

Kim Horowitz

Y

Bryan Benefiel    

Y

Antelope Valley Endocrinology

A Professional Corporation 

Y

Lancaster Rheumatology and Osteoporosis Center, Inc.

Y

Ernest Medical Corporation, Inc.

Y

High Desert Gastroenterology, Inc.    

Y

Chickkiah Padmanabhan

Y

Young J. Ko, MD

A Medical Corporation

Y

Satya Dandamudi

Y

Ric Garrison

Y

Antelope Valley Lung Institute Medical Group

Y

Richard Kling, MD

Y

Kumar Medical Corporation

Y

Patalappa Chandrashekar, MD, Inc.

Y

Doddanna Krishna

A Professional Corporation

Y

Russell Greif

Y

DeSilva Medical, Inc.

Y

Ranjiv Choudhary, MD, Inc.

Y

Vinay Sunku, MD, Inc.

Y

Pradeep K. Singh, MC, Inc.

Y

Kanwaljit S. Gill, MD, Inc.    

Y

 

 

Antelope Valley ACO Participants

Alpine Medical Group | Terry Warsaw, MD

Antelope Valley Cardiology Associates
Antelope Valley Lung Institute
Bryan C Benefiel, MD Inc.
Chikkiah Padmanabhan, MD
Desilva Medical Inc.
Doddanna Krishna  |  A Prof Corp.
Ernest Medical Corp.

Garrison Family Medical Group
Gonzalo Gonzalez Martinez
High Desert Gastroenterology Inc.
K. Sivakumar, MD Inc.
Kanwaljit S. Gill
Kumar Medical Corporation
Lancaster Rheumatology And Osteoporosis Center

Pradeep K. Singh, MD Inc.
Patalappa Chandrashekar, MD Inc.
Ranjiv Choudhary
Ravi S. Shankar, MD

Reen, Amikjit  |  Reen Medical Group
Richard Kling, MD
Russell M. Greif, DO
Satyanarayana Dandamudi, MDA

Sierra Family Care, Kim Horowitz, MD
Sierra Gastroenterology
Vinay Sunku, MD Inc.

Young J. Ko, MD  |  A Medical Corporation

 

Antelope Valley ACO Governing Body

Pamela Desilva, MD

ACO Participant and Voting Member

 

Satya Dandamudi, MD

Voting Member and ChairmanDesilva Medical, Inc.

 

Ric Garrison, MD

ACO Participant and Voting Member

Garrison Family Medical Group

 

Russell Greif, MD

Secretary

Russell M. Greif, DO

 

Pramod Kadambi, MD

ACO Participant and Voting Member

Antelope Valley Cardiology Associates

 

Doddanna Krishna, MD

ACO Participant and Voting Member

Doddanna Krishna, MD

A Professional Corporation

 

Gonzalo Martinez, MD

ACO Participant and Voting Member

Joshua Medical Group

 

Ravi Shankar, MD

Medical Director  |  President

Ravi Shankar, MD, Inc.

 

Kumarasamy Sivakumar, MD

Treasurer

K. Sivakumar, MD, Inc.

 

Vinay Sunku, MD

ACO Participant and Voting Member

Vinay A Sunku, MD, Inc

 

Mrs. Fran Hayes-Bodkin

Voting Member

Medicare Beneficiary Representative

 

Key ACO Clinical and Administrative Leadership
Name Title

Ravi Shankar, MD

ACO Executive
Ravi Shankar, MD Medical Director
Vivek Radhakrishnan Compliance Officer
Doddana Krishna Quality Assurance & Improvement

 

Committee Leadership
Name Title

Russell Greif, MD–Chair

Compliance and Credentialing

Doddanna Krishna, MD–Chair

Quality Assurance & Improvement

Satya Dandamudi, MD–Chair

Utilization

Pramod Kadambi, MD–Chair

Finance

 

Types of ACO participants, or combinations of participants, that formed the ACO:

  • Networks of Individual practices of ACO professionals

 

Shared Savings and Losses

Amount of Shared Savings/Losses

First Agreement Period  

  • Performance Year 2016: $1,532,938
  • Performance Year 2015: $1,398,168
  • Performance Year 2014: $0

 

Shared Savings Distribution

• First Agreement Period

  • Performance Year 2016
  • Proportion Invested in Infrastructure: 30%
  • Proportion Invested in Redesigned Care Processes/Resources: 0%
  • Proportion of Distribution to ACO Participants: 70%
  • Performance Year 2015
  • Proportion Invested in Infrastructure: 20%
  • Proportion Invested in Redesigned Care Processes/Resources: 0%
  • Proportion of Distribution to ACO Participants: 80%
  • Performance Year 2014
  • Proportion Invested in Infrastructure: N/A
  • Proportion Invested in Redesigned Care Processes/Resources: N/A
  • Proportion of Distribution to ACO Participants: N/A

 

Payment Rule Waivers

“No, our ACO does not utilize SNF 3-Day rule waiver.”

 

Quality Performance Results

2016 Quality Performance Results:

ACO#

Measure Name

Rate

ACO Mean

ACO-1

CAHPS: Getting Timely Care, Appointments, and Information

75.28

79.9

ACO-2

CAHPS: How Well Your Providers Communicate

89.34

92.63

ACO-3

CAHPS: Patients' Rating of Provider

90.76

91.93

ACO-4

CAHPS: Access to Specialists

84.75

83.52

ACO-5

CAHPS: Health Promotion and Education

57.62

60

ACO-6

CAHPS: Shared Decision Making

73.27

75.28

ACO-7

CAHPS: Health Status/Functional Status

67.18

71.82

ACO-34

CAHPS: Stewardship of Patient Resources

20.98

27.52

ACO-8

Risk-Standardized, All Condition Readmission

14.95

14.7

ACO-35

Skilled Nursing Facility 30-Day All-Cause Readmission Measure (SNFRM)

18.44

18.17

ACO-36

All-Cause Unplanned Admissions for Patients with Diabetes

57.24

53.2

ACO-37

All-Cause Unplanned Admissions for Patients with Heart Failure

78.34

75.23

ACO-38

All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions

63.18

59.81

ACO-9

Ambulatory Sensitive Conditions Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5)

9.61

9.27

ACO-10

Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8 )

17.16

14.53

ACO-11

Percent of PCPs who Successfully Meet Meaningful Use Requirements

33.33

82.72

ACO-39

Documentation of Current Medications in the Medical Record

98.65

87.54

ACO-13

Falls: Screening for Future Fall Risk

45.08

64.04

ACO-14

Preventive Care and Screening: Influenza Immunization

57.52

68.32

ACO-15

Pneumonia Vaccination Status for Older Adults

45.44

69.21

ACO-16

Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow Up

85.51

74.45

ACO-17

Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention

92.12

90.98

ACO-18

Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan

36.06

53.63

ACO-19

Colorectal Cancer Screening

45.44

61.52

ACO-20

Breast Cancer Screening

55.3

67.61

ACO-21

Preventive Care and Screening: Screening for High Blood Pressure and Follow-up Documented

85.46

76.84

ACO-42

Statin Therapy for the Prevention and Treatment of Cardiovascular Disease

76.34

77.72

ACO-27

Diabetes Mellitus: Hemoglobin A1c Poor Control

23.78

18.24

ACO-41

Diabetes: Eye Exam  

24.37

44.94

ACO-28

Hypertension (HTN): Controlling High Blood Pressure

66.13

70.52

ACO-30

Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic

87.24

85.05

ACO-31

Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)

93.85

88.67

ACO-33

Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy – for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%)

80

79.67

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low samples.

 

 

 

Note: In the Quality Performance Results file(s) above, search for “Antelope Valley ACO, Inc” or "Antelope Valley ACO" to view the quality performance results. This ACO can also be found by using the ACO ID A01307 in the public use files on data.cms.gov.

Print Print | Sitemap
© Antelope Valley ACO, Inc.